You are here: Industry Insights > Hepatitis

News List

FDA changes Hepatitis C Devices Categorization SHEM OIRERE
December 17, 2021
To Support Global efforts to test and treat chronic hepatitis C has received a major boost from the Food and Drug Administration (FDA) after the US-based regulator issued a final order for the reclassification...
FDA Approves PreHevbrio (Hepatitis B Vaccine (Recombinant)) for the Prevention of Hepatitis B in Adults Drugs
December 06, 2021
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that the U.S. Food and Drug Administration...
More than Half of Singaporeans Unaware of Link between Viral Hepatitis and Liver Failure: Survey prnasia
July 28, 2021
The findings of a new survey, commissioned by Gilead Sciences, on Singaporeans' awareness, knowledge and attitudes towards liver health showed that more than half (58%) of the general population do not recognise that viral hepatitis can cause liver ...
New Health Trends® Study by Quest Diagnostics in Collaboration with CDC Reveals Concerning Decreases in Hepatitis C Testing and Treatment During First Months of COVID-19 Pandemic prnewswire
May 12, 2021
A new Quest Diagnostics Health Trends® report developed in collaboration with the Centers for Disease Control and Prevention (CDC) found that the COVID-19 pandemic reduced routine hepatitis C virus (HCV) testing and treatment.
1971 to 2017 Saw 32 Drinking Water Hepatitis A Outbreaks drugs
September 09, 2019
Thirty-two outbreaks of hepatitis A associated with drinking water were identified during 1971 to 2017...
Ionis Licenses Hepatitis B Program to GSK contractpharma
August 28, 2019
Transaction provides Ionis with significant participation in the commercial success of HBV program.
Eiger Receives FDA Breakthrough Therapy Designation for Treatment of Hepatitis Delta Virus Infection americanpharmaceuticalreview
August 22, 2019
Eiger BioPharmaceuticals has announced that the Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for peginterferon lambda (Lambda) for the treatment of hepatitis delta virus (HDV) infection.
Hepatitis A Infections Soaring: CDC drugs
May 10, 2019
Hepatitis A Infections Soaring: CDC.
FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients drugs
May 06, 2019
FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients.
Successful kidney transplants from hepatitis C infected individuals europeanpharmaceuticalreview
April 22, 2019
Transplantation followed by antiviral therapy cured hepatitis C in 100 percent of patients receiving kidneys from infected donors…

Previous page 1 2 Next page